389 articles in this topic
Researchers developed rat and mouse models mimicking early and middle stages of oral submucous fibrosis using bleomycin injections.
Comprehensive review reveals how cancer cells manipulate immune recognition and promising therapeutic strategies to restore T cell immunity.
New research identifies HBO1 as a key driver of cancer cell transformation and resistance to CAR-T cell therapy in ovarian cancer.
Review reveals how cardiolipin dysregulation drives glioblastoma survival and identifies potential therapeutic vulnerabilities.
Scientists discover KLHL6 protein prevents immune cell dysfunction in tumors, offering new target for cancer immunotherapy.
Scientists develop antibodies that stabilize drug-modified KRAS mutations, enabling targeted immune responses across different genetic backgrounds.
Machine learning models achieve 88-97% accuracy in detecting gastric cancer risk through microbiome analysis, opening new paths for early detection.
New research reveals how a metabolic enzyme fuels hepatocellular carcinoma progression through altered lipid synthesis pathways.
New research reveals how tiny cellular packages from aging cells might be engineered to deliver targeted cancer treatments.
Scientists develop advanced drug delivery methods to detect and eliminate harmful senescent tumor cells that promote cancer spread.
New NEJM study compares early treatment with daratumumab versus watchful waiting for high-risk smoldering multiple myeloma patients.
New review reveals how neurotransmitters like norepinephrine and acetylcholine directly regulate immune cells in tumors, opening therapeutic targets.
